Screening for Prostate Cancer, Part I
In two large randomized trials, researchers examined the effect of annual prostate-specific antigen (PSA) screening on the rate of death from prostate cancer and found that it was small and was offset by false positive diagnoses. Since screening may have benefits in catching cancers early but may also carry risks including that of unnecessary treatment, professional societies have split on the question of whether to recommend regular PSA screening. In a roundtable discussion moderated by Dr ...
Author: NEJMvideo; Tags: PSA screening prostate cancer Thomas Lee Philip Kantoff Mary McNaughton-Collins PLCO trial ERSPC trial
